MECHANISMS OF AUTONOMOUS PROLIFERATION OF HUMAN RENAL CANCER CELLS

人肾癌细胞自主增殖机制

基本信息

项目摘要

Since a human renal cancer cell line, SMKT-R3, is able to grow in serum-free media, it is supposed to proliferate autonomously. On the other hand, glycolipid sulfotransferase (GST) is highly expressed in human renal cancer cells. In order to elucidate the mechanisms of autonomous proliferation and GST expression, we performed the following experiments. Genistein, a tyrosine kinase inhibitor, not only cancelled the enhancement of the cell growth by EGF but also completely inhibited the proliferation of non-treated cells and their GST activity. These observations suggested that endogenous tyrosine kinase (s) are involved in the autonomous proliferation and the expression of GST in human renal cancer cells. The fact that 120 kDa tyrosine-phosphorylated protein was detected without EGF treatment indicates that endogenous tyrosine kinase (s) other than the EGF receptor are activated in SMKT-R3 cells. Although the 120 kDa tyrosine-phosphorylated protein was observed on a western blotting, it … More was not able to be precipitated with anti-phosphotyrosine antibody. Therefore, we could not identify the tyrosine kinase that phosphorylates the 120 kDa protein. Then we examined whether Ras is involved. We introduced v-H-ras gene into SMKT-R3 cells and obtained cell lines that stably express activated Ras. The v-Ras expressing cells showed higher GST activity than control cells but their growth rate was not enhanced significantly. The v-Ras expressing cells did not respond to additional EGF because the signal was saturated downstream of the EGF receptor. On the other hand, When genistein was added to the v-Ras expressing cells, the reduction of GST activity was not observed, indicating that the tyrosine kinases including the EGF receptor act upstream of Ras to increase GST activity. However, the growth of v-Ras expressing cells was suppressed by genistein. This suggests that the tyrosine kinases involved in the proliferation act on other points. To inhibit endogenous Ras activity, we introduced a dominant-negative ras gene into SMKT-R3 cells. The dominant-negative Ras expressing cells came to be impossible to grow, suggesting that the endogenous Ras is essential for the autonomous proliferation of renal cancer cells. Less
由于人肾癌细胞系SMKT-R3能够在无血清培养基中生长,因此它应该自主增殖。另一方面,糖脂磺基转移酶(GST)在人肾癌细胞中高度表达。为了阐明自主增殖和GST表达的机制,我们进行了以下实验。酪氨酸激酶抑制剂Genistein不仅能消除EGF对细胞生长的促进作用,而且能完全抑制未处理细胞的增殖和GST活性。这些结果表明,内源性酪氨酸激酶参与了人肾癌细胞的自主增殖和GST表达。在没有EGF处理的情况下检测到120 kDa酪氨酸磷酸化蛋白质的事实表明,在SMKT-R3细胞中除了EGF受体之外的内源性酪氨酸激酶被激活。尽管在蛋白质印迹上观察到120 kDa酪氨酸磷酸化蛋白, ...更多信息 不能用抗磷酸酪氨酸抗体沉淀。因此,我们无法鉴定使120 kDa蛋白磷酸化的酪氨酸激酶。然后我们检查了Ras是否参与其中。我们将v-H-ras基因导入SMKT-R3细胞,获得了稳定表达活化Ras的细胞株。表达v-Ras的细胞表现出比对照细胞更高的GST活性,但它们的生长速率没有显著提高。表达v-Ras的细胞对额外的EGF没有反应,因为EGF受体下游的信号饱和。另一方面,当向表达v-Ras的细胞中加入染料木黄酮时,没有观察到GST活性的降低,表明包括EGF受体在内的酪氨酸激酶在Ras上游起作用以增加GST活性。然而,v-Ras表达细胞的生长被染料木黄酮抑制。这表明参与增殖的酪氨酸激酶作用于其他点。为了抑制内源性Ras活性,我们将显性负性ras基因导入SMKT-R3细胞。显性阴性表达Ras的细胞不能生长,表明内源性Ras对肾癌细胞的自主增殖是必需的。少

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Balbaa, M.: "Regulation of glycolipid sulfotransferase by tyrosine kinases in human renal cancer cells." Biochim.Biophys.Acta. 1299. 141-145 (1996)
Balbaa, M.:“人肾癌细胞中酪氨酸激酶对糖脂磺基转移酶的调节。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Balbaa, M., Honke, K., and Makita, A.: "Regulation of glycolipid sulfotransferase by tyrosine kinases in human renal cencer cells" Biochim.Biophys.Acta. 1299. 141-145 (1996)
Balbaa, M.、Honke, K. 和 Makita, A.:“人肾癌细胞中酪氨酸激酶对糖脂磺基转移酶的调节”Biochim.Biophys.Acta。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Honke, K., Tsuda, M., et al.: "Molecular cloning and expression of cDNA encoding human 3'-phosphoadenylsulfate : galactosylceramide 3'-sulfotransferase" J.Biol.Chem.272 (8). 4864-4868 (1997)
Honke, K.、Tsuda, M. 等人:“编码人 3-磷酸腺苷硫酸酯:半乳糖苷神经酰胺 3-磺基转移酶的 cDNA 的分子克隆和表达”J.Biol.Chem.272 (8)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Balbaa,M.: "Regulation of glycolipid sulfotransferase by tyrosine kinases in human renal cancer cells." Biochim.Biophys.Acta. 1299. 141-145 (1996)
Balbaa,M.:“人肾癌细胞中酪氨酸激酶对糖脂磺基转移酶的调节。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Honke, K.: "Molecular cloning and expression of cDNA encoding human 3′-phosphoadenylylsulfate : galactosylceramide 3′-sulfotransferase." J.Biol.Chem.272. 4864-4868 (1997)
Honke, K.:“编码人 3-磷酸腺苷基硫酸盐:半乳糖神经酰胺 3-磺基转移酶的 cDNA 的分子克隆和表达。J.Biol.Chem.272 (1997)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HONKE Koichi其他文献

HONKE Koichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HONKE Koichi', 18)}}的其他基金

Identification of sialyl Lewis antigen carrier proteins involved in the metastasis of lung cancer and development of diagnostic method to measure them
鉴定参与肺癌转移的唾液酸Lewis抗原载体蛋白并开发测量它们的诊断方法
  • 批准号:
    25670166
  • 财政年份:
    2013
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Bioinformation Produced by Molecular Interactions in The Membrane Microdomains
膜微域中分子相互作用产生的生物信息
  • 批准号:
    22659060
  • 财政年份:
    2010
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Molecular Mechanisms to Regulate The Metabolism of Water and Electrolytes
调节水和电解质代谢的分子机制
  • 批准号:
    21390096
  • 财政年份:
    2009
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Production of autoantibodies and an animal model of autoimmune disease using a knockoutmouse
使用基因敲除小鼠生产自身抗体和自身免疫性疾病动物模型
  • 批准号:
    15590271
  • 财政年份:
    2003
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Biological roles of sulfated glycolipids and pathophysiology of their deficiency
硫酸化糖脂的生物学作用及其缺乏的病理生理学
  • 批准号:
    14082204
  • 财政年份:
    2002
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
SULFATED GLYCOLIPID THAT REGULATES DEVELOPMENT OF MALE GERM CELLS
调节雄性生殖细胞发育的硫酸糖脂
  • 批准号:
    13670138
  • 财政年份:
    2001
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Study on resistance of lung cancer cells to inhibitor of EGF receptor tyrosine kinase
肺癌细胞对EGF受体酪氨酸激酶抑制剂耐药的研究
  • 批准号:
    20590077
  • 财政年份:
    2008
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ADAM10 as a gatekeeper of receptor tyrosine kinase activation and trafficking: comparative analysis of cell-morphogenetic and mitogenic Eph and EGF receptor signalling pathways
ADAM10 作为受体酪氨酸激酶激活和运输的看门人:细胞形态发生和促有丝分裂 Eph 和 EGF 受体信号通路的比较分析
  • 批准号:
    72455513
  • 财政年份:
    2008
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Research Fellowships
Development of vesicular traffic by the EGF receptor-tyrosine kinase
EGF 受体酪氨酸激酶引起的囊泡运输的发展
  • 批准号:
    155751-1998
  • 财政年份:
    2001
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Discovery Grants Program - Individual
Development of vesicular traffic by the EGF receptor-tyrosine kinase
EGF 受体酪氨酸激酶引起的囊泡运输的发展
  • 批准号:
    155751-1998
  • 财政年份:
    2000
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Discovery Grants Program - Individual
Development of vesicular traffic by the EGF receptor-tyrosine kinase
EGF 受体酪氨酸激酶引起的囊泡运输的发展
  • 批准号:
    155751-1998
  • 财政年份:
    1999
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Discovery Grants Program - Individual
SELECTIVE INHIBITION OF EGF RECEPTOR TYROSINE KINASE
EGF 受体酪氨酸激酶的选择性抑制
  • 批准号:
    6020311
  • 财政年份:
    1999
  • 资助金额:
    $ 1.47万
  • 项目类别:
SELECTIVE INHIBITION OF EGF RECEPTOR TYROSINE KINASE
EGF 受体酪氨酸激酶的选择性抑制
  • 批准号:
    6211046
  • 财政年份:
    1999
  • 资助金额:
    $ 1.47万
  • 项目类别:
SELECTIVE INHIBITION OF EGF RECEPTOR TYROSINE KINASE
EGF 受体酪氨酸激酶的选择性抑制
  • 批准号:
    6362694
  • 财政年份:
    1999
  • 资助金额:
    $ 1.47万
  • 项目类别:
Development of vesicular traffic by the EGF receptor-tyrosine kinase
EGF 受体酪氨酸激酶引起的囊泡运输的发展
  • 批准号:
    155751-1998
  • 财政年份:
    1998
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Discovery Grants Program - Individual
Regulation of the EGF receptor-tyrosine kinase
EGF受体酪氨酸激酶的调节
  • 批准号:
    155751-1994
  • 财政年份:
    1997
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了